Literature DB >> 6895132

Immunohistological studies on primary reticulosis of the canine brain.

M Vandevelde, R Fatzer, R Fankhauser.   

Abstract

Brains of 17 dogs with primary reticulosis, and of two with metastatic and one with primary lymphosarcoma, were examined by immunohistologic techniques with antisera against the major immunoglobulin classes of the dog. On the basis of immunoglobulin in tumour cells, two reticuloses were reclassified as primary lymphosarcomas of the brain. The tumour cells in three other dogs with neoplastic reticulosis and in six dogs with microgliomatosis did not contained immunoglobulin. Many cells in inflammatory reticulosis were immunoglobulin-bearing. Although some of these lesions could have been lymphosarcomas, insufficient data were available to ascertain either an inflammatory or a neoplastic nature. It was concluded that some lesions previously classified as reticulosis are in fact primary histiocytic lymphosarcomas of the brain, while others may be true reticulosarcomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895132     DOI: 10.1177/030098588101800502

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  4 in total

1.  Focal thoracolumbar spinal cord lymphosarcoma in a ferret (Mustela putorius furo).

Authors:  Joelle C Ingrao; David Eshar; Andrew Vince; Bridget Lee-Chow; Stephanie Nykamp; Josepha DeLay; Dale Smith
Journal:  Can Vet J       Date:  2014-07       Impact factor: 1.008

2.  Granulomatous meningoencephalomyelitis in dogs: A review.

Authors:  Emma J O'Neill; Darren Merrett; Boyd Jones
Journal:  Ir Vet J       Date:  2005-02-01       Impact factor: 2.146

Review 3.  Myelitis and meningitis.

Authors:  D C Sorjonen
Journal:  Vet Clin North Am Small Anim Pract       Date:  1992-07       Impact factor: 2.093

4.  Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.

Authors:  Molly E Church; Guadalupe Ceja; Megan McGeehan; Miles C Miller; Priscilla Farias; Melissa D Sánchez; Gary P Swain; Charles-Antoine Assenmacher; Edward G Stopa; Charles H Vite; Amit Bar-Or; Jorge I Alvarez
Journal:  J Immunol       Date:  2021-06-23       Impact factor: 5.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.